The Discounted Cash Flow (DCF) valuation of Onconova Therapeutics Inc (ONTX) is (1,071.38) USD. With the latest stock price at 4.46 USD, the upside of Onconova Therapeutics Inc based on DCF is -24097.3%.
Based on the latest price of 4.46 USD and our DCF valuation, Onconova Therapeutics Inc (ONTX) is a sell. selling ONTX stocks now will result in a potential gain of 24097.3%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 4.8% - 5.8% | 5.3% |
| Long-term Growth Rate | 3.0% - 4.5% | 3.8% |
| Fair Price | (6,310.33) - (595.68) | (1,071.38) |
| Upside | -141441.5% - -13442.4% | -24097.3% |